Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure

European Journal of Heart Failure

Volumn 14, Issue 1, 2012, Pages 54-60

  Van Craenenbroeck, Emeline M ^a   Pelle, Aline J ^b   Beckers, Paul J ^a   Possemiers, Nadine M ^a   Ramakers, Christian ^c   Vrints, Christiaan J ^a   Van Hoof, Viviane ^a   Denollet, Johan ^b   Conraads, Viviane M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b TILBURG UNIVERSITY   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Chronic heart failure; Exercise intolerance; Red cell distribution width

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

ADULT; AEROBIC CAPACITY; ARTICLE; CARDIAC PATIENT; CARDIOPULMONARY EXERCISE TEST; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEDENTARY LIFESTYLE;

AGED; CHRONIC DISEASE; ERYTHROCYTE INDICES; EXERCISE MOVEMENT TECHNIQUES; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; PHYSICAL FITNESS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 84555209187     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr136     Document Type: Article

References (26)

1. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009;169:588-594.
2. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-168.
3. Anderson JL, Ronnow BS, Horne BD, Carlquist JF, May HT, Bair TL, Jensen KR, Muhlestein JB. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol 2007;99:169-174. (Pubitemid 46072753)
4. Horne BD, May HT, Kfoury AG, Renlund DG, Muhlestein JB, Lappe DL, Rasmusson KD, Bunch TJ, Carlquist JF, Bair TL, Jensen KR, Ronnow BS, Anderson JL. The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints. Eur J Heart Fail 2010;12:1203-1213.
5. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-47. (Pubitemid 46963527)
6. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010;12:129-136.
7. Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 2009;11:1155-1162.
8. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width: a powerful prognostic marker in heart failure. Eur J Heart Fail 2010;12:415.
9. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF Jr. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010;16:230-238.
10. Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 2007;116:329-343. (Pubitemid 47196569)
11. Minetti M, Agati L, MalorniW. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 2007;75:21-28. (Pubitemid 46873513)
12. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ. Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 1999;34:1170-1175. (Pubitemid 29500556)
13. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352: 1011-1023.
14. Vlahakos DV, Marathias KP, Madias NE. The role of the renin-angiotensin system in the regulation of erythropoiesis. Am J Kidney Dis 2010;56:558-565.
15. Wasserman K, Hansen JE, Sue DY, Whipp B. Principles of Exercise Testing and Interpretation. Philadelphia: Lea & Febiger; 1987.
16. Beckers PJ, Denollet J, PossemiersNM,Wuyts FL, VrintsCJ,ConraadsVM. Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J 2008;29:1858-1866.
17. Jackson CE, Dalzell JR, Bezlyak V, Tsorlalis IK, Myles RC, Spooner R, Ford I, Petrie MC, Cobbe SM, McMurray JJ. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail 2009;11:1152-1154.
18. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sanchez-Mas J, Garrido IP, Valdes M. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009;11:840-846.
19. von Haehling S, Jankowska EA, Anker SD. Tumour necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications. Basic Res Cardiol 2004;99:18-28. (Pubitemid 38049136)
20. Keteyian SJ, Fleg JL, Brawner CA, Pina IL. Role and benefits of exercise in the management of patients with heart failure. Heart Fail Rev 2010;15:523-530.
21. Keteyian SJ, Houston Miller N, Ellis SJ, O'Connor CM, Whellan DJ, Cooper LS, Lee KL, Leifer ES, Kraus WE, Fleg JL, Kitzman DW, Blumenthal JA, Rendall DS, Issac D, Cohen-Solal A, Flynn KE, Lin L, Weinfurt KP, Piña IL. A dose-response analysis of patients with heart failure enrolled in a controlled trial investigating outcomes of exercise training (HF-ACTION). 58th Annual Scientific Session of the American College of Cardiology. Orlando, Florida; 2009.
22. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-1450.
23. Conraads VM, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, Brutsaert DL. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002;23:1854-1860. (Pubitemid 35398054)
24. Niebauer J, Clark AL, Webb-Peploe KM, Coats AJ. Exercise training in chronic heart failure: effects on pro-inflammatory markers. Eur J Heart Fail 2005;7: 189-193. (Pubitemid 40215611)
25. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003;42:861-868. (Pubitemid 37059745)
26. Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH. Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 2010;12:676-684.